Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
IBOthis companyImpact BioMedical Inc.	$4.03	-1.33×	1.26×	497.66×	-1.27×	-100.4%	-1225.0%	-13343.8%	-36993.8%	-93.9%	-21.6%	-11.9%	0×	0×	-5.38×	0.35×	0.0%	4	2.31	2	C+
AIMAIM ImmunoTech Inc.	$0.16	-0.13×	-0.19×	20.78×	-0.45×	-2271.9%	-284.1%	-11961.4%	-15861.4%	142.7%	-313.6%	-619.7%	-0.5×	-0.31×	-12.96×	0.53×	0.0%	3	-51.36	2	C
QNRXQuoin Pharmaceuticals, Ltd.	$3.86	-1.36×	1.65×	0×	241.74×	63270.6%	0.0%	0.0%	0.0%	-120.5%	-109.7%	-62.6%	0×	243.12×	0×	3.61×	0.0%	1	-13.64	2	C+
TCRTAlaunos Therapeutics, Inc.	$1.76	-1.47×	2.92×	1,258.64×	-1.18×	-81.2%	-27160.0%	-84500.0%	-83520.0%	-194.0%	-196.2%	-47.1%	0×	0.33×	0×	2.45×	0.0%	1	-860.38	1	C-
XBIOXenetic Biosciences, Inc.	$1.91	-1.37×	0.5×	1.24×	1.56×	-1576.3%	100.0%	-95.2%	-90.1%	-36.2%	-38.3%	-61.9%	0×	2.94×	0×	8.32×	0.0%	3	-36.91	1	C-
Peer median	—	-1.37×	1.07×	11.01×	0.56×	-828.8%	-142.0%	-6028.3%	-7975.7%	-78.4%	-153.0%	-62.3%	0×	1.64×	0×	3.03×	0.0%	2	-44.14	2	—